380 related articles for article (PubMed ID: 6449567)
41. Technetium-99m-labeled methylene diphosphonate and hydroxyethylidine diphosphonate--biologic and clinical comparison: concise communication.
Rudd TG; Allen DR; Smith FD
J Nucl Med; 1979 Aug; 20(8):821-6. PubMed ID: 120422
[TBL] [Abstract][Full Text] [Related]
42. A clinical comparison of Tc-99m HEDP and Tc-99m MDP.
Coupal JJ; Kim EE
J Nucl Med; 1979 Aug; 20(8):896-7. PubMed ID: 120424
[No Abstract] [Full Text] [Related]
43. Kinetics of 99mTc-tin-methylene diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism.
Coupal JJ
Calcif Tissue Int; 1981; 33(5):555. PubMed ID: 6797708
[No Abstract] [Full Text] [Related]
44. Influence of complex charge and size on the uptake of 99mTc-diphosphonates in osteogenic tissue.
Pinkerton TC; Cheng KT; Shaw SM; Wilson GM
Int J Rad Appl Instrum B; 1986; 13(1):49-56. PubMed ID: 3095270
[TBL] [Abstract][Full Text] [Related]
45. [Uptake of 99mTc-MDP by the lung and liver].
Ohchida T; Ichiya A; Matsuura K; Ooiwa T
Rinsho Hoshasen; 1984 Mar; 29(3):437-8. PubMed ID: 6235386
[No Abstract] [Full Text] [Related]
46. Calcification and uptake of Tc-99m diphosphonates in neuroblastomas: concise communication.
Martin-Simmerman P; Cohen MD; Siddiqui A; Mirkin D; Provisor A
J Nucl Med; 1984 Jun; 25(6):656-60. PubMed ID: 6233408
[TBL] [Abstract][Full Text] [Related]
47. 99mTc(CO)3-labeled pamidronate and alendronate for bone imaging.
Palma E; Correia JD; Oliveira BL; Gano L; Santos IC; Santos I
Dalton Trans; 2011 Mar; 40(12):2787-96. PubMed ID: 21301703
[TBL] [Abstract][Full Text] [Related]
48. Diphosphonates in the evaluation of metabolic bone disease.
Fogelman I; Smith ML
Clin Rheumatol; 1982 Mar; 1(1):41-4. PubMed ID: 6236012
[TBL] [Abstract][Full Text] [Related]
49. Reaction of 99mTc-diphosphonate with N-donor ligands.
Johannsen B
Int J Appl Radiat Isot; 1982 Jun; 33(6):429-32. PubMed ID: 6286510
[No Abstract] [Full Text] [Related]
50. Primary neuroblastoma uptake of 99mtechnetium methylene diphosphonate.
Smith FW; Gilday DL; Ash JM; Reid RH
Radiology; 1980 Nov; 137(2):501-4. PubMed ID: 6449027
[TBL] [Abstract][Full Text] [Related]
51. [An experience with 99mTc-hydroxy methylene diphosphonate (99mTc-HMDP) as a new bone scanning agent].
Hayasaka K; Arakawa K; Sugie H; Amoh K
Radioisotopes; 1984 Oct; 33(10):714-6. PubMed ID: 6522651
[No Abstract] [Full Text] [Related]
52. A novel (99m)Tc-labeled diphosphonic acid as potential bone seeking agent: synthesis and biological evaluation.
Qiu L; Cheng W; Lin J; Zhang S; Luo S
Curr Radiopharm; 2013 Mar; 6(1):28-35. PubMed ID: 23256753
[TBL] [Abstract][Full Text] [Related]
53. 99mTc bone scanning agents--II. Adsorption of 99mTc(Sn)pyrophosphate complexes on the mineral phase of bone.
Kroesbergen J; van Steijn AM; Gelsema WJ; de Ligny CL
Int J Nucl Med Biol; 1986; 12(6):411-7. PubMed ID: 3011692
[TBL] [Abstract][Full Text] [Related]
54. A radiopharmaceutical and clinical comparison of 99mTc-Sn-hydroxymethylene diphosphonate with 99mTc-Sn-hydroxyethylidene diphosphonate.
Silberstein EB
Radiology; 1980 Sep; 136(3):747-51. PubMed ID: 6773104
[TBL] [Abstract][Full Text] [Related]
55. [Local blood flow and bone uptake of methylene-diphosphonate-technetium-99m. 2].
Vattimo A; Martini G
Boll Soc Ital Biol Sper; 1983 Nov; 59(11):1614-7. PubMed ID: 6230088
[No Abstract] [Full Text] [Related]
56. Factors influencing the distribution of 99m-technetium methylene diphosphonate in bone and soft tissues.
Khan RA
Experientia; 1978 Dec; 34(12):1598-600. PubMed ID: 32068
[TBL] [Abstract][Full Text] [Related]
57. A clinical comparison of MDP and DMAD.
Rosenthall L; Stern J; Arzoumanian A
Clin Nucl Med; 1982 Sep; 7(9):403-6. PubMed ID: 6214358
[TBL] [Abstract][Full Text] [Related]
58. Concentration of Tc-99m methylenediphosphonate in hepatic metastases from squamous cell carcinoma.
Wilkinson RH; Gaede JT
J Nucl Med; 1979 Apr; 20(4):303-5. PubMed ID: 317096
[TBL] [Abstract][Full Text] [Related]
59. Factors affecting uptake and retention of technetium-99m-diphosphonate and 99m-pertechnetate in osseous, connective and soft tissues.
Francis MD; Slough CL; Tofe AJ
Calcif Tissue Res; 1976 Jun; 20(3):303-11. PubMed ID: 182328
[TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetic and imaging evaluation of (99m)Tc-HBIDP as a potential bone imaging agent.
Qiu L; Lin J; Nan B; Lv G; Cheng W
Pak J Pharm Sci; 2015 May; 28(3):815-8. PubMed ID: 26004712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
